BCK Capital Management’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-54,293
| Closed | -$303K | – | 82 |
|
|
2022
Q3 | $303K | Hold |
54,293
| – | – | 0.22% | 62 |
|
|
2022
Q2 | $212K | Hold |
54,293
| – | – | 0.16% | 67 |
|
|
2022
Q1 | $299K | Hold |
54,293
| – | – | 0.18% | 105 |
|
|
2021
Q4 | $463K | Buy |
54,293
+834
| +2% | +$7.11K | 0.31% | 76 |
|
|
2021
Q3 | $465K | Buy |
53,459
+13,222
| +33% | +$115K | 0.28% | 93 |
|
|
2021
Q2 | $425K | Buy |
40,237
+8,910
| +28% | +$94.1K | 0.21% | 102 |
|
|
2021
Q1 | $502K | Buy |
+31,327
| New | +$502K | 0.28% | 96 |
|